Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.

Journal: The Lancet. Oncology

Publication date: 2015

Journal: The Lancet. Oncology

Publication Year: 2015

Authors & Co-authors:  Franz David Neal DN Belousova Elena E Sparagana Steven S Bebin E Martina EM Frost Michael M Kuperman Rachel R Witt Olaf O Kohrman Michael H MH Flamini J Robert JR Wu Joyce Y JY

Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM.

Journal: BMC medicine

Publication date: 2023

Journal: BMC medicine

Publication Year: 2023

Authors & Co-authors:  Müller Annelieke R AR Luijten Michiel A J MAJ Haverman Lotte L de Ranitz-Greven Wendela L WL Janssens Peter P Rietman André B AB Ten Hoopen Leontine W LW de Graaff Laura C G LCG de Wit Marie-Claire MC Jansen Anna C AC

Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM.

Journal: BMC medicine

Publication date: 

Journal: BMC medicine

Publication Year: 

Authors & Co-authors:  Müller Annelieke R AR Luijten Michiel A J MAJ Haverman Lotte L de Ranitz-Greven Wendela L WL Janssens Peter P Rietman André B AB Hoopen Leontine W Ten LWT de Graaff Laura C G LCG de Wit Marie-Claire MC Jansen Anna C AC